Influenza D Virus Entry and Tissue Tropism
D 型流感病毒进入和组织趋向性
基本信息
- 批准号:10240750
- 负责人:
- 金额:$ 51.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-21 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAffinityAgreementAnimalsAntiviral AgentsAsiaBindingBiologicalCarbonCattleCaviaCellsChimeric ProteinsComparative StudyDataDependenceDevelopmentDiseaseDisease OutbreaksDistantEndocytosisEquus caballusEuropeFamily suidaeFerretsGeneticGenomeHealthHumanImmunityInfectionInfluenzaInfluenza A virusInfluenza C VirusInfluenza D VirusInfluenza preventionInvestigationLeadLightMembrane FusionMolecularMutationN-Acetylneuraminic AcidN-glycolylneuraminic acidOklahomaPathway interactionsPeriodicalsPolysaccharidesPositioning AttributePublic HealthResearchResearch PriorityResistanceRuminantsSerologySialic AcidsSpecificityStructureTissuesTropismVaccinesViralViral GenomeVirusVirus DiseasesVirus ReceptorsWorkZoonosesbasechemical groupcross-species transmissionextracellularhemagglutinin esteraseinfluenzavirusinsightnovelnovel strategiespreferencereceptorreceptor bindingsialic acid receptortissue tropismtraitvirus tropism
项目摘要
PROJECT SUMMARY
Novel influenza D virus (IDV) utilizes bovines as a primary reservoir with periodical spillover to
other mammalian hosts including pigs and horses. Of greater public health importance, serological
evidence of IDV infections in humans has been demonstrated. Preliminary investigations have revealed
that IDV binds to human 9-O-acetylated N-acetylneuraminic acid (Neu5,9Ac2), the receptor of human
influenza C virus (ICV), and non-human N-glycolylneuraminic acid (Neu5Gc9Ac) and likely utilizes
them for viral entry. Further functional studies indicate that IDV is more efficient in recognizing both
human Neu5,9Ac2- and non-human Neu5Gc9Ac-containing glycans than ICV, and ICV seems to
preferentially bind to human Neu5,9Ac2 over non-human Neu5Gc9Ac. In agreement with this, ICV has
a limited host range with humans as a reservoir. These results suggest that IDV and ICV diverge in
communicating with sialic acids (SA) for infection. The hypothesis is that subtle differences in the
sequence and structure of the receptor-binding pocket residing in the hemagglutinin-esterase-fusion
(HEF) protein between IDV and ICV cause substantial differences in the virus-receptor interaction,
which can expand or reduce, or change tissue and species tropisms. Furthermore, the recent
observation on the extracellular resistance of IDV to low pH inactivation versus the intracellular
requirement of low pH for viral entry suggests a novel entry/fusion mechanism by which IDV employs
to deliver its genome into the target cell. Three aims are proposed to address these hypotheses in this
R01 application, which involve a comparative study of IDV and ICV. Aim 1 will elucidate the entry
mechanism of IDV, while Aim 2 will define the molecular basis of the HEF receptor binding affinity and
specificity and its impact on IDV tropism. Aim 3 is deigned to address how two IDV lineages, swine and
bovine, read the glycan receptors differentially and how this information is transduced to different
tissue and species tropisms between these two groups of IDVs. In summary, this proposal leverages the
team's expertise in IDV research and novel aspects of IDV-receptor interaction and entry to elucidate
the cross-species transmission mechanism of IDVs. Understanding molecular details of virus-receptor
interaction may lead to development of novel strategies for the control and prevention of IDV and ICV
infections in humans.
项目摘要
新型D型流感病毒(IDV)利用牛作为周期性溢出的主要宿主,
其他哺乳动物宿主,包括猪和马。更重要的公共卫生,血清学
IDV在人类中感染的证据已经得到证实。初步调查显示
IDV结合人9-O-乙酰化N-乙酰神经氨酸(Neu5,9Ac2),人的受体
C型流感病毒(ICV)和非人N-羟乙酰神经氨酸(Neu5Gc9Ac),并可能利用
病毒进入。进一步的功能研究表明,IDV在识别这两个方面更有效
人Neu5,9Ac 2-和非人Neu5Gc9Ac-含聚糖的浓度高于ICV,ICV似乎
相对于非人Neu5Gc9Ac,其优先结合人Neu5,9Ac 2。为此,ICV
宿主范围有限,人类是宿主。这些结果表明,IDV和ICV的分歧,
与唾液酸(SA)沟通以进行感染。假设是,
位于血凝素-酯酶-融合物中的受体结合口袋的序列和结构
(HEF)IDV和ICV之间的蛋白质引起病毒-受体相互作用的实质性差异,
其可以扩张或缩小,或改变组织和物种向性。此外,最近
观察IDV对低pH灭活的细胞外抗性与细胞内抗性,
病毒进入所需的低pH值提示了一种新的进入/融合机制,
将其基因组导入靶细胞。本文提出了三个目标来解决这些假设。
R01应用,其中涉及IDV和ICV的比较研究。目标1将阐明条目
目的2将定义HEF受体结合亲和力的分子基础,
特异性及其对IDV向性的影响。目的3是为了解决两个IDV谱系,猪和
牛,阅读聚糖受体的差异,以及如何将这些信息转导到不同的
这两组IDV之间的组织和物种向性。总而言之,本提案利用了
团队在IDV研究和IDV-受体相互作用的新方面的专业知识,
IDV的跨物种传播机制。了解病毒受体的分子细节
相互作用可能会导致开发控制和预防IDV和ICV的新策略
人类感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FENG LI其他文献
FENG LI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FENG LI', 18)}}的其他基金
A novel assay for inhibitors of influenza A virus polymerase complex assembly
甲型流感病毒聚合酶复合物组装抑制剂的新测定法
- 批准号:
7921295 - 财政年份:2009
- 资助金额:
$ 51.83万 - 项目类别:
Mechanism of action of an HIV-1 maturation inhibitor
HIV-1 成熟抑制剂的作用机制
- 批准号:
8304325 - 财政年份:2008
- 资助金额:
$ 51.83万 - 项目类别:
Mechanism of action of an HIV-1 maturation inhibitor
HIV-1 成熟抑制剂的作用机制
- 批准号:
7683909 - 财政年份:2008
- 资助金额:
$ 51.83万 - 项目类别:
Mechanism of action of an HIV-1 maturation inhibitor
HIV-1 成熟抑制剂的作用机制
- 批准号:
8110561 - 财政年份:2008
- 资助金额:
$ 51.83万 - 项目类别:
A novel assay for inhibitors of influenza A virus polymerase complex assembly
甲型流感病毒聚合酶复合物组装抑制剂的新测定法
- 批准号:
7533709 - 财政年份:2008
- 资助金额:
$ 51.83万 - 项目类别:
Mechanism of action of an HIV-1 maturation inhibitor
HIV-1 成熟抑制剂的作用机制
- 批准号:
7496229 - 财政年份:2008
- 资助金额:
$ 51.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 51.83万 - 项目类别:
Research Grant